The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy
Cancer Cell · 2024-06 · 42 (6) · 919-922
DOI: 10.1016/j.ccell.2024.04.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-06. Verfasst von Matheus Henrique Dias und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Ministerie van Volksgezondheid, Welzijn en Sport, Dutch Cancer Society, Oncode Institute.
Abstract (Originalsprache)
Most targeted cancer drugs inhibit the oncogenic signals to which cancer cells are addicted. We discuss here a counterintuitive approach to cancer therapy, which consists of deliberate overactivation of the oncogenic signals to overload the stress responses of cancer cells. We discuss why such overactivation of oncogenic signaling, combined with perturbation of the stress response pathways, can be potentially effective in killing cancer cells, aiming to inspire further discussion and consideration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: r.bernards@nki.nl.
Förderung
- Ministerie van Volksgezondheid, Welzijn en Sport
- Dutch Cancer Society
- Oncode Institute
Zitieren
APA
Dias, M. H., Papagianni, C., & Bernards, R. (2024). The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy. Cancer Cell, 42(6), 919-922. https://doi.org/10.1016/j.ccell.2024.04.014
Vancouver
Dias MH, Papagianni C, Bernards R. The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy. Cancer Cell. 2024;42(6):919-922. doi:10.1016/j.ccell.2024.04.014
BibTeX
@article{Dias2024,
author = {Dias, Matheus Henrique and Papagianni, Chrysa and Bernards, Rene},
title = {The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {6},
pages = {919--922},
doi = {10.1016/j.ccell.2024.04.014}
}
EUVIMED